Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Litigation / Medical Malpractice News

Mississippi Files Medicaid Fraud Lawsuit Against Eli Lilly Over Marketing For Off-Label Prescriptions

Main Category: Litigation / Medical Malpractice
Also Included In: Medicare / Medicaid / SCHIP;  Pharma Industry / Biotech Industry
Article Date: 31 Jul 2006 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:5 stars

5 (1 votes)

Article Opinions: 0 posts

Mississippi on Tuesday filed a lawsuit in Lafayette County Circuit Court against Indianapolis-based Eli Lilly over allegations that the pharmaceutical company improperly marketed the antipsychotic drug Zyprexa for "off-label" uses, "defraud[ing] the state out of millions of dollars in Medicaid reimbursements," the Jackson Clarion Ledger reports. The suit alleges that representatives for Eli Lilly convinced Mississippi doctors to prescribe the drug to patients who suffered from anxiety, mood swings and disturbed sleep while the drug was approved only for treatment of bipolar disorder and schizophrenia. The suit also alleges that the pharmaceutical company did not properly emphasize the dangers of the drug, such as an increased risk of diabetes. Those Medicaid beneficiaries who became ill from the drug consequently increased the state's Medicaid expenditures, the suit states. The suit alleges damages of $30 million in prescription costs alone, and the state also will seek civil penalties, punitive damages and litigation costs, Tim Balducci, Mississippi special assistant attorney general, said. Zyprexa, which is among the top drugs paid for by Medicaid, was improperly marketed "in an attempt to expand the market share of the drug," Balducci said. He added that Eli Lilly targeted the state of Mississippi because its Medicaid system does not stringently oversee the prescription of drugs for off-label uses. Eli Lilly has 30 days to respond to the suit. A spokesperson for the company did not comment on the suit (Joyner, Jackson Clarion Ledger, 7/25).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

View drug information on Zyprexa.





Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Please fill in our survey

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Criticism Of Popular Oral Contraceptive Yaz Could Harm Product's Appeal, New York Times Reports
29 Sep 2009
The popular oral contraceptives Yaz and Yasmin have been tainted recently by safety concerns raised by researchers, health advocates and lawyers for plaintiffs who have filed lawsuits against manufacturer Bayer Healthcare, the New York Times reports...


Keeping Seniors Safe in the Heat
Keeping Seniors Safe in the Heat

Keeping cool this summer means avoiding heat stroke, the most serious heat-related illness, and heat exhaustion, a milder affliction but still a dangerous one. Older people are especially vulnerable to both.

more videos are available in our health videos section.